Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedAn NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study-record page, and the site revision changes from v3.7.1 to v3.7.2. The study record itself remains inaccessible behind a 403 Forbidden error.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check25 days agoChange DetectedAn error state (403 Forbidden) is now displayed on the page, replacing the study details and navigation with a standard error screen. This indicates access to the study record is denied.SummaryDifference19%

- Check39 days agoChange DetectedThe label 'Find Contact Information' was standardized to 'Find contact information'. The UI revision tag changed from 'Revision: v3.6.6' to 'Revision: v3.7.0'.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.6.6 is now shown on the page, indicating an updated release of the ClinicalTrials.gov interface; the change is a behind-the-scenes update to the site version rather than a change to the study information.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now displays Revision: v3.6.5, signaling a new build/version of the site. This is a metadata update and does not alter the study details.SummaryDifference0.0%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.